Beyond Side Effects: The Role of Dissociation in Esketamine Therapy for Treatment-Resistant Depression

Paper. Ben Ari Y, Bloemhof-Bris E, Pardo-Aviv L et al.. Journal of Trauma & Dissociation, 18 Nov 2026.

Tags: Human, Ketamine, Depression.

Weekly Science Digest, 13 Nov 2026 to 19 Nov 2026, finding 1: Does the experience matter? Two more attempts

Stronger subjective effects went with better depression outcomes across 3,637 ketamine patients.

In a telehealth programme giving up to four sublingual doses over four weeks, pre-registered analyses found higher scores on a five-item psychedelic intensity scale at week two predicted greater PHQ-9 improvement. A separate chart review of 51 esketamine patients found trait dissociation tracked baseline depression severity and was elevated in those with trauma comorbidity.

How much weight it carries: Large pre-registered analysis of an existing telehealth cohort; shows association between rated intensity and symptom change, not that the experience causes the benefit. (Humans, Observational, Retrospective, Industry, No control group, n = 3,637)

Read the original

—
Node—
Statuslive
Throughput—